RecruitingNCT07193069

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning


Sponsor

Centre Hospitalier de Saint-Denis

Enrollment

50 participants

Start Date

Apr 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with dapagliflozin, diabetic ketoacidosis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centre Hospitalier de Saint-Denis

Saint-Denis, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07193069


Related Trials